BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for ESSA Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-14 5:30 pm Sale | 2025-10-09 | 13D | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -11,668,473 (Position Closed) | Filing |
| 2025-08-07 4:31 pm Purchase | 2025-08-05 | 13D | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 11,668,473 24.700% | 2,919,844 (+33.37%) | Filing |
| 2025-04-09 09:00 am Unchanged | 2025-04-09 | 13D | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.700% | 0 (Unchanged) | Filing |
| 2022-07-12 4:40 pm Purchase | 2022-07-08 | 13G | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.900% | 4,183,387 (+91.64%) | Filing |
| 2022-02-14 1:43 pm Purchase | 2021-12-31 | 13G | ESSA PHARMA INC EPIX | BIOTECHNOLOGY VALUE FUND L P | 4,565,242 9.990% | 859,953 (+23.21%) | Filing |